Bangladeshi (DSE) Pharma Industry Analysis
UpdatedOct 28, 2023
DataAggregated Company Financials
Companies17
- 7D0.008%
- 3M0.3%
- 1Y-7.3%
- YTD-1.6%
The Pharma is pretty flat in the last 7 days, but Ambee Pharmaceuticals has stood out, gaining 30%. As for the longer term, the industry has declined 7.9% in the last year. As for the next few years, earnings are expected to grow by 12% per annum.
Industry Valuation and Performance
Has the Bangladeshi Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 29 Oct 2023 | ৳530.6b | ৳202.3b | ৳31.7b | 27.4x | 16.7x | 2.6x |
| Tue, 26 Sep 2023 | ৳528.2b | ৳201.9b | ৳31.7b | 30.4x | 16.6x | 2.6x |
| Thu, 24 Aug 2023 | ৳528.9b | ৳201.9b | ৳31.7b | 31.4x | 16.7x | 2.6x |
| Sat, 22 Jul 2023 | ৳532.2b | ৳201.9b | ৳31.7b | 35.4x | 16.8x | 2.6x |
| Mon, 19 Jun 2023 | ৳530.3b | ৳201.9b | ৳31.7b | 36.3x | 16.7x | 2.6x |
| Wed, 17 May 2023 | ৳526.5b | ৳201.7b | ৳31.8b | 29x | 16.5x | 2.6x |
| Fri, 14 Apr 2023 | ৳524.5b | ৳197.0b | ৳33.4b | 25.9x | 15.7x | 2.7x |
| Sun, 12 Mar 2023 | ৳534.7b | ৳197.0b | ৳33.4b | 27.1x | 16x | 2.7x |
| Tue, 07 Feb 2023 | ৳543.2b | ৳192.9b | ৳33.4b | 30.2x | 16.2x | 2.8x |
| Thu, 05 Jan 2023 | ৳538.6b | ৳189.6b | ৳33.9b | 28.1x | 15.9x | 2.8x |
| Sat, 03 Dec 2022 | ৳550.0b | ৳180.7b | ৳34.4b | 23.9x | 16x | 3x |
| Mon, 31 Oct 2022 | ৳576.2b | ৳175.6b | ৳34.9b | 24.7x | 16.5x | 3.3x |
| Wed, 28 Sep 2022 | ৳566.7b | ৳172.6b | ৳34.7b | 25.1x | 16.3x | 3.3x |
| Fri, 26 Aug 2022 | ৳542.1b | ৳172.6b | ৳34.7b | 25.2x | 15.6x | 3.1x |
| Sun, 24 Jul 2022 | ৳517.9b | ৳172.6b | ৳34.7b | 19.8x | 14.9x | 3x |
| Tue, 21 Jun 2022 | ৳536.2b | ৳172.6b | ৳34.7b | 22x | 15.4x | 3.1x |
| Thu, 19 May 2022 | ৳539.9b | ৳172.7b | ৳34.8b | 22.9x | 15.5x | 3.1x |
| Sat, 16 Apr 2022 | ৳553.9b | ৳169.2b | ৳34.3b | 24.8x | 16.1x | 3.3x |
| Mon, 14 Mar 2022 | ৳537.4b | ৳169.2b | ৳34.3b | 25.5x | 15.6x | 3.2x |
| Wed, 09 Feb 2022 | ৳568.6b | ৳169.3b | ৳34.4b | 24.8x | 16.5x | 3.4x |
| Fri, 07 Jan 2022 | ৳548.5b | ৳166.5b | ৳32.5b | n/a | 16.9x | 3.3x |
| Sun, 05 Dec 2021 | ৳558.2b | ৳156.6b | ৳29.8b | 26.4x | 18.7x | 3.6x |
| Tue, 02 Nov 2021 | ৳552.8b | ৳145.7b | ৳25.5b | 27.1x | 21.7x | 3.8x |
| Thu, 30 Sep 2021 | ৳587.8b | ৳151.5b | ৳25.7b | 29.1x | 22.9x | 3.9x |
| Sat, 28 Aug 2021 | ৳546.0b | ৳151.7b | ৳25.7b | 26.8x | 21.2x | 3.6x |
| Sun, 04 Jul 2021 | ৳482.3b | ৳151.7b | ৳25.7b | 23.6x | 18.8x | 3.2x |
| Wed, 07 Apr 2021 | ৳445.7b | ৳151.7b | ৳25.7b | 21.8x | 17.3x | 2.9x |
| Sat, 09 Jan 2021 | ৳460.1b | ৳148.4b | ৳24.6b | 21.7x | 18.7x | 3.1x |
Price to Earnings Ratio
16.3x
Current Industry PE
- Investors are relatively neutral on the Bangladeshi Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 17.3x.
- The 3-year average PS ratio of 3.1x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 10.0% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Bangladeshi Pharma compare with similar industries?
| BD Market | -0.12% | |
| Healthcare | -0.038% | |
| Pharma | 0.0078% | |
| Pharma | 0.0078% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AMBEEPHA Ambee Pharmaceuticals | ৳1.15k | 30.4% +৳646.1m | 137.3% | PE291.2x | |
| LIBRAINFU Libra Infusions | ৳1.69k | 25.5% +৳516.5m | 91.3% | n/a | |
| ORIONINFU Orion Infusion | ৳329.80 | 2.5% +৳164.9m | -66.1% | PE158.2x |